Victory Capital Management Inc Novo Cure LTD Transaction History

Victory Capital Management Inc

$146 Billion
Q2 2025

A detailed history of Victory Capital Management Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Victory Capital Management Inc holds 11,807 shares of NVCR stock, worth $165,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,807

Previous 11,925 0.99%

Holding current value

$165,888

Previous $212,000 0.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$15.37 - $19.4 $1,813 - $2,289	-118 Reduced 0.99%	11,807 $210,000
Q1 2025 May 02, 2025	SELL	$17.82 - $30.19 $2,084 - $3,532	-117 Reduced 0.97%	11,925 $212,000
Q4 2024 Feb 06, 2025	SELL	$14.54 - $33.41 $4,696 - $10,791	-323 Reduced 2.61%	12,042 $358,000
Q3 2024 Nov 05, 2024	SELL	$15.61 - $23.34 $2,310 - $3,454	-148 Reduced 1.18%	12,365 $193,000
Q2 2024 Aug 05, 2024	SELL	$11.83 - $24.05 $1,940 - $3,944	-164 Reduced 1.29%	12,513 $214,000
Q1 2024 May 03, 2024	SELL	$12.42 - $17.29 $4,371 - $6,086	-352 Reduced 2.7%	12,677 $198,000
Q4 2023 Feb 05, 2024	BUY	$11.13 - $15.78 $145,012 - $205,597	13,029 New	13,029 $194,000
Q4 2021 Feb 07, 2022	SELL	$75.08 - $121.99 $181,693 - $295,215	-2,420 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$116.17 - $194.55 $49.9 Million - $83.6 Million	-429,934 Reduced 99.44%	2,420 $281,000
Q2 2021 Aug 03, 2021	SELL	$130.4 - $225.58 $13.3 Million - $22.9 Million	-101,708 Reduced 19.04%	432,354 $95.9 Million
Q1 2021 May 04, 2021	BUY	$124.11 - $190.17 $10.3 Million - $15.8 Million	83,276 Added 18.47%	534,062 $70.6 Million
Q4 2020 Feb 01, 2021	BUY	$112.16 - $174.14 $45.9 Million - $71.3 Million	409,159 Added 982.92%	450,786 $78 Million
Q3 2020 Nov 09, 2020	BUY	$58.05 - $111.31 $517,225 - $991,772	8,910 Added 27.23%	41,627 $4.63 Million
Q2 2020 Aug 07, 2020	SELL	$57.2 - $74.41 $95,867 - $124,711	-1,676 Reduced 4.87%	32,717 $1.94 Million
Q1 2020 May 04, 2020	SELL	$57.05 - $95.75 $1.72 Million - $2.89 Million	-30,209 Reduced 46.76%	34,393 $2.32 Million
Q4 2019 Feb 06, 2020	BUY	$68.3 - $93.8 $712,642 - $978,709	10,434 Added 19.26%	64,602 $5.44 Million
Q4 2019 Feb 04, 2020	BUY	$68.3 - $93.8 $1.36 Million - $1.87 Million	19,945 Added 58.28%	54,168 $4.41 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $2.12 Million - $3.35 Million	34,223 New	34,223 $2.56 Million

Others Institutions Holding NVCR

# of Institutions

284

Shares Held

77.5M

Call Options Held

943K

Put Options Held

155K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.47B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Novo Cure LTD Transaction History